Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
Luís Henrique Angenendt da Costa, Bruna M. Santos, Luiz G.S. Branco
Topics & Concepts
NeuroprotectionSerotoninNeurotransmitterReuptakeReuptake inhibitorMedicineInflammationImmune systemCoronavirus disease 2019 (COVID-19)PathophysiologySerotonin Uptake InhibitorsNeurosciencePharmacologySystemic inflammationCentral nervous systemImmunologyPsychologyInternal medicineDiseaseReceptorFluoxetineInfectious disease (medical specialty)Pharmacological Receptor Mechanisms and EffectsLong-Term Effects of COVID-19Vagus Nerve Stimulation Research